healthcare companies vs countries

3 Dec

Country

Gross Domestic Product (GDP)

US$ billions

Company

total annual  revenues

US$ billions

 Croatia

60,83

Johnson & Johnson

61,90

 Dominican Republic

51,62

Pfizer

50,01

 Slovenia

47,73

Roche

47,35

 Burma

45,42

GlaxoSmithKline

45,83

 Tunisia

44,27

Novartis

44,27

 Guatemala

41,17

Sanofi

41,99

 Ghana

32,32

AstraZeneca

32,81

 Ethiopia

29,71

Abbott Laboratories

30,76

 Panama

26,808

Merck & Co.

27,43

 Cameroon

22,522

Bayer HealthCare

22,30

 El Salvador

21,215

Eli Lilly

21,84

 Paraguay

18,427

Bristol-Myers Squibb

18,81

Two days ago I participated to a medical congress where an interesting pharmacy professor listed to the impressed congress participants the incomes of pharmaceutical companies. Listening to the colossal amount of yearly incomes generated by the treatments of the inhabitants of the richest countries of the planet (poor countries can’t afford to pay for medics so the companies don’t develop their markets with them) I suddenly asked to myself if the gross income product of developing countries wouldn’t be overrated by the yearly incomes of the pharmaceutical companies. Back home I gathered the data to construct the table you can read above. Each drug company has the same economic power as at least one country.

 

Related articles:

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: